Cardiovascular Biomaterials SIG Activities

Cardiovascular Biomaterials Special interest group aims to bring together researchers from academia, industry and the clinic with the common interest related to cardiovascular applications. The objectives of this SIG is to:

  • suggesting, organizing, and implementing symposia, workshops, tutorials, and general scientific sessions at the SFB Annual Meeting and other SFB-sponsored meetings
  • providing networking opportunities for researchers in cardiovascular application to foster new collaboration
  • enhance education in the area of cardiovascular biomaterials and bioengineering, by contributing articles to relevant publications and organizing educational sessions at meetings
  • collaborate with other SIGs to further the goals of the Society as a whole, and to promote advances in biomedical materials research in a broad range of applications

Following is a list of the Cardiovascular related sessions that will be held at the SFB 2022 Annual Meeting:

Anti-Thrombogenic Coatings/Biomaterials for Vascular Applications

Thrombosis and intimal hyperplasia have been the major complications of bypass graft surgery. Autologous vessels are the gold standard for bypass graft surgeries. However, due to unavailability of healthy autologous arteries, synthetic polymers have been widely employed for the fabrication of vascular grafts. Synthetic polymers are associated with high rates of thrombosis and intimal hyperplasia especially small diameter vessels and low flow blood velocity zones. Hence, there has been extensive research performed on coatings and surface modification strategies to improve the performance of endovascular devices and grafts. This symposium will highlight some of the recent in vitro and in vivo research and advancements in surface modification techniques/characterization and biomaterial coatings that can prevent the events and incidence of thrombosis and intimal hyperplasia. This session will also include review of abstracts on next generation biomaterials that have the potential to promote endothelialization and prevent inflammation.

Cardiovascular Biomanufacturing

Biomanufacturing is an emerging field for developing technologies to fabricate bio-related products using natural or synthetic or hybrid biomaterials, and cells and cell-based products. This session will highlight the development and application of 3D printed cardiovascular products, organoids, organ-on-chips, vascularized constructs, and other related products for cardiovascular engineering.

Cardiovascular Biomaterials (SIG)

The Cardiovascular Special Interest Group has the mission to foster the professional interaction and address the common concerns of academic and industrial scientists and engineers, clinicians, and regulatory professionals concerned with the discovery, research, development, and use of biomaterials for cardiovascular devices and implants.

Functionality of Engineered Cardiovascular Tissues

A hallmark of successful biomaterials is their ability to match or improve upon native tissue function. This is especially true for biomaterials employed in the cardiovascular system. The dynamic nature of the cardiovascular system makes in vitro and in vivo evaluation of cardiac function an interesting field of study. This session will highlight approaches to augment and/or evaluate functionality of engineered cardiovascular tissues. This may include (but is not limited to) quantification and imaging of cardiac rhythm, myocardial strain, vessel strength, computational modeling and electrophysiology.

Naturally Derived Biomaterials for Cardiovascular Engineering

Although a variety of biomaterials have been utilized to engineer cardiovascular tissues, naturally derived biomaterials remain the ones that exhibit the best effects in tissue regeneration and remodeling. The symposium will overview the state of the art of strategies to engineer cardiovascular tissues with various naturally derived biomaterials, such as cell and tissue derived extracellular matrices and their components. Various emerging approaches, including 3D/4D printing, self-assembling, and spatially patterning, will be discussed. This symposium will include an invited talk from a leader in cardiovascular engineering, who utilize both natural derived biomaterials and advanced engineering technologies to create cardiovascular tissues. This symposium will also highlight other outstanding work in this area from SFB members, through the submitted abstracts.

Translation of Tissue Engineering for Cardiovascular Applications

This session is designed to foster greater interaction and collaboration among biomaterial engineers, basic biologists, and clinicians. Speakers will discuss biomaterials-based strategies of engineering of cardiovascular tissues and subsequent testing in preclinical or clinical stages. Topics of interest include vascular grafts, valves, cardiac patches, and engineered therapeutic cells.

 

 

SFB News

Sponsored by the BioInterfaces SIG (BioI) and Burroughs Wellcome Fund (BWF), this annual award recognizes outstanding BioInterfaces research by postdoc-level scientists.